Medicine

Heart disease risk scores fail in Vietnamese and Southeast Asian populations

AI Insight

This study evaluated four European-derived polygenic risk scores for coronary artery disease in 2,504 individuals from the 1000 Genomes Project, with focus on Vietnamese populations. The researchers found that these scores substantially over-predict genetic risk in Vietnamese and Southeast Asian populations, incorrectly flagging 22-58% of individuals as high-risk when applying European thresholds that should identify only 20%. The degree of miscalibration varied depending on which specific polygenic score was used, indicating that these European-derived tools cannot be reliably transferred to Southeast Asian populations without local validation.


Clinical use of unadjusted European polygenic scores in Vietnamese and Southeast Asian patients could lead to misclassification of cardiovascular risk, potentially causing unnecessary medical interventions, patient anxiety, and inefficient healthcare resource allocation. This highlights the critical need for ancestry-specific calibration of genetic risk tools before implementation in diverse populations.


Understand the Science

Cardiovascular disease 33 articles Explore Concept → Population genetics Concept coming soon

⚠️ Preprint – Noch nicht peer-reviewed

Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.

Background. Polygenic scores (PRS) for coronary artery disease (CAD) are derived almost entirely from European-ancestry data. Their portability to Southeast Asian populations, including the Vietnamese, is largely uncharacterised and clinically consequential when scores are used with risk thresholds. Methods. We evaluated four independent European-derived CAD scores from the PGS Catalog (PGS000058, PGS000349, PGS002809, PGS004198; 70 – 5,723 variants) in 2,504 individuals from the 1000 Genomes Project, focusing on the Vietnamese Kinh (KHV) and Dai (CDX) samples. Per-individual scores were computed with PLINK2 and standardised. We assessed (i) the cross-ancestry distribution (calibration) and (ii) a clinically-relevant consequence: the proportion of each population flagged high genetic risk when the European top-20% threshold is applied (20% if perfectly calibrated). Results. For the primary score (PGS000058) the standardised PRS differed across super-populations (ANOVA F(4, 2499) = 121.1, p < 0.001); the Vietnamese Kinh mean was +0.47 SD above the European mean (Welch t = 7.77, p = 2.0 x 10^ -14). Applying the European top-20% high-risk threshold, the fraction of Vietnamese Kinh flagged ranged from 22.2% to 57.6% across the four scores, and of Dai from 21.5% to 43.0%, versus the intended 20%. Three of the four scores over-flagged Vietnamese (25-58%); the largest score (PGS004198) was approximately calibrated for East/Southeast Asians ([~]22%) but markedly over-flagged Africans (69.3%). Conclusions. European-derived CAD polygenic scores are inconsistently calibrated in Vietnamese and other Southeast Asian samples, and most substantially over-flag high genetic risk when a European threshold is applied. The magnitude and even the direction of miscalibration depend on the specific score, so no such score can be assumed transferable without local validation and recalibration. Distribution shift bounds, but does not by itself quantify, loss of predictive accuracy, which requires phenotyped data.

Source: European-derived coronary artery disease polygenic scores over-flag genetic risk in Vietnamese and Southeast Asian populations: a multi-score analysis in 1000 Genomes